Cantuzumab ravtansine is a humanized monoclonal antibody designed for the treatment of cancers. The antibody
cantuzumab is linked to a cytotoxic agent, ravtansine.
The source of this article is
wikipedia, the free encyclopedia. The text of this article is licensed under the
GFDL.
